Taiwan has experienced a clear upswing in HIV infection among injection drug users (IDUs) since 2004. Unsafe drug injection behavior has led to complicated infections including HIV and hepatitis C virus infection among IDUs. Nurses face challenges and threats in caring for this group due to the widespread criminal and behavioral problems related to drug use. The purpose of this phenomenological study was to explore nurses' experiences in caring for HIV positive IDUs. Purposive sampling was used to recruit 7 nurses with experience working with HIV positive IDUs. In-depth semi-structured interviews were conducted 1~2 times with each nurse. The length of interviews ranged from 1.5~3 hours. Interviews were tape recorded and transcribed verbatim. Data was analyzed using the Colaizzi method for phenomenology. Nurse experiences reflected low achievement level, difficulty in establishing rapport with IDUs, fear of drug use incidences during hospitalization, insufficiency and complications with family caregivers, fear of being threatened, and lack of support from other medical disciplines. Nurses used strategies that included being supportive of one another, learning appropriate communication skills, positive thinking, and anticipating substantial compensation from administrators. The results of this study provide essential information for in-service education and healthcare policy reform on IDU care. Interventions to ease nurse anxieties and feelings of insecurity in order to increase safe care should be developed and implemented. Positive feedback from IDUs with HIV infection enhances nurses' professional and personal growth.

Download full-text PDF

Source

Publication Analysis

Top Keywords

injection drug
8
hiv infection
8
hiv positive
8
positive idus
8
idus
6
drug
5
hiv
5
[the experience
4
nurses
4
experience nurses
4

Similar Publications

Modern ART is evolving, allowing the use of new drug formulations and alternative routes of administration to oral therapy. Long-acting (LA) cabotegravir and rilpivirine, the first fully injectable antiretroviral regimen approved for clinical use, is a test case for this new route of administration, and an innovation with implications for the quality of life of people with HIV (PWH). However, its use requires a reorganization of outpatient clinics and outpatient services, and a number of issues remain to be defined regarding the management of PWH on LA drugs, including the correct selection of people who can be treated with LA cabotegravir and rilpivirine.

View Article and Find Full Text PDF

The advent of biomacromolecules antagonizing vascular endothelial growth factor (VEGF) has revolutionized the treatment of neovascular age-related macular degeneration (nAMD). However, frequent intravitreal injections of these biomacromolecules impose an enormous burden on patients and create a massive workload for healthcare providers. This causes patients to abandon therapy, ultimately leading to progressive and irreversible vision loss.

View Article and Find Full Text PDF

Rusfertide, a peptide hepcidin mimetic, has shown efficacy in polycythemia vera. This trial investigated the multiple-dose pharmacokinetics, pharmacodynamics, and safety of once-weekly rusfertide 60 mg for 5 weeks in healthy subjects. Subjects were randomized to subcutaneous injection in the abdomen, upper arm, or thigh.

View Article and Find Full Text PDF

Background And Purpose: Phentolamine is a non-selective α-adrenoreceptor antagonist used to reverse local anaesthesia, for example, during dental procedures when a vasoconstrictor is co-applied. Phentolamine-mediated vasodilation leads to faster clearance of injected drugs. Previous electrophysiological studies hypothesized that phentolamine acts as a modulator of voltage-gated sodium channels, which could conflict with its indication as local anaesthetic reversal agent.

View Article and Find Full Text PDF

Background: Anti-Activin Receptor Type IIA and Type IIB antibody (αActRIIA/IIB ab) is a recently developed drug class that targets the activin receptor signalling pathway. Inhibition of receptor ligands (activins, myostatin, growth differentiation factor 11, etc.) can lead to skeletal muscle hypertrophy, bone formation, and increased haematopoiesis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!